Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 Jul 21 424B4 Prospectus supplement with pricing info
- 9 Jul 21 EFFECT Notice of effectiveness
- 2 Jun 21 S-1/A IPO registration (amended)
- 3 May 21 S-1/A IPO registration (amended)
- 16 Apr 21 S-1/A IPO registration (amended)
- 8 Apr 21 S-1/A IPO registration (amended)
- 24 Mar 21 S-1/A IPO registration (amended)
-
26 Feb 21 S-1 IPO registration
RNAZ similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated February 26, 2021 which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, relating to the financial statements of Transcode Therapeutics, Inc. as of December 31, 2020 and 2019. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC | |
East Brunswick, New Jersey | |
February 26, 2021 |